OSENI 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

oseni 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - alogliptin benzoate, quantity: 34 mg (equivalent: alogliptin, qty 25 mg); pioglitazone hydrochloride, quantity: 33.06 mg (equivalent: pioglitazone, qty 30 mg) - tablet, film coated - excipient ingredients: titanium dioxide; mannitol; hypromellose; lactose monohydrate; hyprolose; macrogol 8000; croscarmellose sodium; magnesium stearate; iron oxide yellow; purified talc; microcrystalline cellulose; iron oxide red; shellac; ethanol absolute; iron oxide black; 1-butanol - oseni is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and pioglitazone is appropriate,- when treatment with metformin or pioglitazone alone does not provide adequate control; or,- in combination with metformin when dual therapy does not provide adequate control.,oseni can also be used to replace separate tablets of alogliptin and pioglitazone in patients already being treated with this combination.

NESINA PIO 12.5/15 12.5 mg alogliptin (as benzoate) / 15 mg pioglitazone (as hydrochloride) film-coated tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 12.5/15 12.5 mg alogliptin (as benzoate) / 15 mg pioglitazone (as hydrochloride) film-coated tablet bottle

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

NESINA PIO 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet bottle

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

NESINA PIO 12.5/30 12.5 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 12.5/30 12.5 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

NESINA PIO 25/45 25 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 25/45 25 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

NESINA PIO 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 25/30 25 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

NESINA PIO 12.5/45 12.5 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 12.5/45 12.5 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

NESINA PIO 25/15 25 mg alogliptin (as benzoate) / 15 mg pioglitazone (as hydrochloride) film-coated tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 25/15 25 mg alogliptin (as benzoate) / 15 mg pioglitazone (as hydrochloride) film-coated tablet bottle

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

NESINA PIO 12.5/30 12.5 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet bottle Австралия - английски - Department of Health (Therapeutic Goods Administration)

nesina pio 12.5/30 12.5 mg alogliptin (as benzoate) / 30 mg pioglitazone (as hydrochloride) film-coated tablet bottle

takeda pharmaceuticals australia pty ltd - alogliptin benzoate,pioglitazone hydrochloride -

OSENI 25/45 25 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

oseni 25/45 25 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - alogliptin benzoate, quantity: 34 mg (equivalent: alogliptin, qty 25 mg); pioglitazone hydrochloride, quantity: 49.59 mg (equivalent: pioglitazone, qty 45 mg) - tablet, film coated - excipient ingredients: iron oxide red; purified talc; croscarmellose sodium; lactose monohydrate; hyprolose; mannitol; microcrystalline cellulose; hypromellose; titanium dioxide; magnesium stearate; macrogol 8000; shellac; ethanol absolute; iron oxide black; 1-butanol - oseni is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and pioglitazone is appropriate,- when treatment with metformin or pioglitazone alone does not provide adequate control; or,- in combination with metformin when dual therapy does not provide adequate control.,oseni can also be used to replace separate tablets of alogliptin and pioglitazone in patients already being treated with this combination.